S La Seta Catamancio

Author PubWeight™ 6.32^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Susceptibility to PNU-140690 (Tipranavir) of human immunodeficiency virus type 1 isolates derived from patients with multidrug resistance to other protease inhibitors.	Antimicrob Agents Chemother	2000	1.17
2	Loss of lamivudine resistance in a zidovudine and lamivudine dual-resistant HIV-1 isolate after discontinuation of in vitro lamivudine drug pressure.	Antivir Ther	1998	1.10
3	A genotypic analysis of patients receiving Zidovudine with either Lamivudine, Didanosine or Zalcitabine dual therapy using the LiPA point mutation assay to detect genotypic variation at codons 41, 69, 70, 74, 184 and 215.	J Clin Virol	2000	0.84
4	Response to antiretroviral therapy in a patient with an uncommon codon 69 insertion in the human immunodeficiency virus type 1 reverse transcriptase.	Antimicrob Agents Chemother	2000	0.82
5	Combination of CCR5 and CXCR4 inhibitors in therapy of human immunodeficiency virus type 1 infection: in vitro studies of mixed virus infections.	J Virol	2000	0.79
6	In vitro inhibition of HIV-1 by Met-SDF-1beta alone or in combination with antiretroviral drugs.	Antivir Ther	2000	0.77
7	Virological response in multidrug-experienced HIV-1-infected subjects failing highly active combination regimens after shifting from lamivudine to didanosine.	Antivir Ther	2001	0.76